CARBAMAZEPINE - ANVISA Registration 80254180388

Access comprehensive regulatory information for CARBAMAZEPINE in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80254180388 and manufactured by MICROGENICS CORPORATION. The registration is held by PHADIA DIAGNOSTICOS LTDA with validity until May 31, 2031.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT GMBH, ROCHE DIAGNOSTICS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80254180388
2 Related Devices
Registration Details
ANVISA Registration Number: 80254180388
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

CEDIA Carbamazepine II Assay
Risk Class III

Registration Details

80254180388

25351284126202119

04930429000139

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

May 31, 2021

31/05/2031

09/18/2025 19:00:01

CEDIA Carbamazepine II Assay
Risk Class III

Registration Details

80254180388

25351284126202119

04930429000139

Company Information

Dates and Status

May 31, 2021

31/05/2031

09/18/2025 19:00:01